Advanced Drainage Systems has clawed back 5% this week to $138.09, yet the dominant story right now is a coordinated wave of analyst target cuts that arrived almost immediately after the May 21 earnings print.
The Street's message is consistent: still bullish, but recalibrating. Stephens & Co. upgraded WMS to Overweight on May 27 — notable given the direction of travel — while simultaneously cutting its target from $190 to $175. Oppenheimer maintained Outperform but trimmed to $190 from $195. UBS and Keybanc both held their Buy and Overweight ratings respectively, yet lowered targets to $205 and $185. The pattern is one of retained conviction with reduced upside assumptions. The consensus remains a buy rating with seven analysts on that side, and the mean price target of $180 implies roughly 30% upside from current levels — a gap that, while wide, has narrowed meaningfully from the $195–$215 range that anchored targets just three months ago. The bull case rests on structural demand in stormwater and septic water management, while bears point to construction cyclicality, inflationary pressure on margins, and integration risk from acquisitions.
Valuation multiples confirm the post-earnings reset. The trailing P/E runs near 20.6x, down roughly 0.9 points over the past month. EV/EBITDA has ticked up slightly to 11.0x over the same window, suggesting the earnings compression has been more visible in per-share metrics than in the enterprise view. Forward EPS growth momentum ranks in the 77th percentile on a 12-month basis — the longer-term earnings trajectory still looks constructive even as near-term estimate momentum (11th percentile on 30 days) reflects the post-print downward revisions.
Positioning in the lending market offers no drama. Short interest has drifted lower by about 11% over the past month, now running at 3.5% of the free float — a modest and declining level. Borrowing cost is just 0.42% annualised, unchanged in character from the levels noted ahead of earnings. Availability is exceptionally loose at 1,348%, meaning there are more than 13 shares available to borrow for every one already out on loan. This is a wide-open borrow market with no squeeze pressure whatsoever. The ORTEX short score of 37.8 sits comfortably in the lower half of the range, consistent with a stock that short sellers are treating as a low-priority position.
Options, by contrast, have flipped noticeably more bullish since the earnings date. The put/call ratio dropped to 0.87, running about 1.5 standard deviations below its 20-day average of 1.02. Through early May, the PCR was persistently above 1.0 — reflecting the hedging caution evident in the pre-earnings note published here on May 18. That protective demand has evaporated. The shift doesn't necessarily signal a strong conviction rally, but it does mean options traders are no longer paying up for downside protection the way they were heading into the print.
On the earnings reaction itself, the May 21 result produced a modest 2.8% one-day decline — a measured response relative to what a 9% month-to-date drawdown might have implied. The next scheduled event is June 18, which the company lists as a separate reporting date; that proximity means any further analyst revisions or management commentary between now and then will land in a relatively tight window. The peer group has broadly recovered alongside WMS this week — JBI leads with an 8.8% weekly gain, OC is up 7%, and GFF added 4.3% — which reinforces the read that building products names are bouncing as a cohort rather than WMS recovering on idiosyncratic factors. How the June 18 event resolves the gap between the current price and analyst targets north of $175 is the next test worth watching.
See the live data behind this article on ORTEX.
Open WMS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
